Modulation by muscarinic antagonists of the response to carbon dioxide challenge in panic disorder

Archives of General Psychiatry

Volumn 58, Issue 2, 2001, Pages 114-119

  Battaglia, M ^a   Bertella, S ^a   Ogliari, A ^a   Bellodi, L ^a   Smeraldi, E ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE; BIPERIDEN; BROMAZEPAM; CARBON DIOXIDE; DELORAZEPAM; ETIZOLAM; MUSCARINIC RECEPTOR BLOCKING AGENT; PIRENZEPINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ANXIETY; ARTICLE; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERCAPNIA; HYPERVENTILATION; MALE; MENTAL DISEASE; PANIC; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE;

EID: 0035130494     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.58.2.114     Document Type: Article

References (41)

1. Pharmacological challenges in anxiety disorders
2. 2 vulnerability in panic disorder
3. 2 challenge
4. False suffocation alarms, spontaneous panic, and related conditions
5. A neuroanatomical hypothesis for panic disorder
6. Respiratory psychophysiology of panic disorder: Three respiratory challenges in 98 subjects
7. Behavioral and neuroendocrine responses to sodium lactate infusion in subjects with posttraumatic stress disorder
8. Toward an integrated neurobiology of panic disorder
9. Catecholamines and pathogenesis in panic disorder
10. Role of ventrolateral medulla in the regulation of respiratory and cardiovascular systems
11. CSF acidosis augments ventilation through cholinergic mechanisims
12. Rostral ventrolateral medulla muscarinic receptors involvement in central ventilatory chemosensitivity
13. Ventral medulla muscarinic receptor subtypes involved in cardiorespiratory control
14. Acetylcholine and central respiratory control: Perturbations of acetylcholine synthesis in the isolated brainstem of the neonatal rat
15. Localization of putative neural respiratory regions in human by functional MRI
16. Effects of M1 selective antimuscarinics in respiratory chemosensitivity in humans
17. Age at onset of panic disorder: Influence of familial liability to the disease and of childhood separation anxiety disorder
18. Anticipation of age at onset in panic disorder
19. The Panic-Associated Symptoms Scale: Measuring the severity of panic disorder
20. Pirenzepine: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases
21. Brain regional pharmacokinetics of biperiden in rats
22. Pharmacokinetic and pharmacodynamic studies following the intravenous and oral administration of the antiparkinsonian drug biperiden to normal subjects
23. 2 challenge in panic disorder: Optimization by receiver operating characteristic analysis
24. 2 challenge in nonclinical subjects
25. Attenuation of carbon dioxide-induced panic after clonazepam treatment
26. 2-induced panic attacks: A twin study
27. 2 challenge of patients with panic disorder
28. Carbon dioxide/oxygen challenge test in panic disorder
29. The brain nucleus locus coeruleus: Restricted afferent control of a broad efferent network
30. The origin of the reticulospinal fibers in the cat: An experimental study
31. Primary alveolar hypoventilation (Ondine's curse) in an infant without external arcuate nucleus
32. Anxiety and central hypoventilation syndrome
33. Decreased muscarinic receptor binding in the arcuate nucleus in sudden infant death syndrome
34. 2 inhalation procedure: Test-retest reliability
35. Search for pathophysiology of panic disorder
36. Pharmacologic effect of imipramine, paroxetine, and sertraline on 35% carbon dioxide hypersensitivity in panic patients: A double-blind, random, placebo-controlled study